# Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effect-of-anlotinib-as-a-third-line-or-further-treatment-on-overall-survival-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Baohui Han,Kai Li,Qiming Wang,Li Zhang,Jianhua Shi,Zhehai Wang,Ying Cheng,Jianxing He,Yuankai Shi,Yizhuo Zhao,Hao Yu,Yang Zhao,Weiqiang Chen,Yi Luo,Lin Wu,Xiuwen Wang,Robert Pirker,Kejun Nan,Faguang Jin,Jian Dong,Baolan Li,Yan Sun |
| Citations | 627 |
| DOI | 10.1001/jamaoncol.2018.3039 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://jamanetwork.com/journals/jamaoncology/articlepdf/2696341/jamaoncology_han_2018_oi_180061.pdf |
| OpenAlex ID | https://openalex.org/W2885503610 |
| PMID | 30098152 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Baohui Han](https://scholariq.org/researchers/baohui-han/)
- [Lin Wu](https://scholariq.org/researchers/lin-wu/)

## Paper journal

- [JAMA Oncology](https://scholariq.org/journals/jama-oncology/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.